![Dor Biopharma](/common/images/company/A_DOR.png)
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today the first successful evaluation in animal tests of a nasal, bivalent combination of its botulinum toxin...
DOR BioPharma, Inc. ("DOR" or the "Company") (AMEX:DOR) announced that it has entered into definitive agreements for the sale of securities in a private placement to institutional investors...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company") announced today its financial results for 2005. ? Revenues for 2005 were $3,075,736 compared to $997,482 in 2004. The revenue in both years...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today that it is focusing its resources on the preparation of New Drug Application ("NDA") and Marketing...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") today announced results of a Phase I clinical trial of RiVax(TM), a recombinant vaccine against ricin toxin, that has been completed...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") today announced that it has successfully completed the second development milestone for its ricin vaccine, called RiVax(TM), under the...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR", or the "Company") announced today that as part of its process to submit a New Drug Application ("NDA") for orBec(R) (oral beclomethasone dipropionate) for...
DOR BioPharma, Inc. ("DOR" or the "Company") (AMEX:DOR), today announced that it has entered into a common stock purchase agreement with Fusion Capital Fund II, LLC, a Chicago based institutional...
DOR BioPharma, Inc. (AMEX:DOR) ("DOR" or the "Company"), announced today that following written communications and meetings with the FDA and with the comparable regulatory authorities of...
DOR BioPharma Inc. (AMEX: DOR) ("DOR" or the "company") announced today its financial results for the third quarter ended Sept. 30, 2005. The company will host a conference call on Wednesday, Nov...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Symbol | Price | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 39.73 (-0.48%) | 82.36M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | $ 22.41 (0.99%) | 51.18M |
SPYSPDR S&P 500 | $ 554.31 (0.22%) | 42.99M |
FXIiShares China Large Cap | $ 26.36 (2.01%) | 34.04M |
HYGiShares iBoxx Dollar High Yield Corporate Bond | $ 78.84 (0.32%) | 33.68M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.